18 completed, 3 not yet recruiting, 2 recruiting, 2 unknown. 25 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 25 | Completed 18, Not yet recruiting 3, Recruiting 2, Unknown 2 |
Follow Leishmaniasis: new trials by email Literature Review of Leishmaniasis trials Research Report on Leishmaniasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immersive Technology Headsets to Reduce Procedural Pain and Anxiety: Feasibility and Effects in Cutaneous Leishmaniasis Patients in Pakistan Virtual Reality - Cutaneous Leishmaniasis, Pain | Not applicable | Not yet recruiting | Stanford University | 15 | 2027-01-01 | 2026-10-05 |
| Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers A mobile app with AI functionality for diagnosing skin-related NTDs - Skin and Connective Tissue Diseases, Neglected Tropical Diseases | Not applicable | Not yet recruiting | Kenya Medical Research Institute | 2420 | 2026-05-01 | 2026-04-02 |
| Human Bioequivalence Study of Liposomal Amphotericin B for Injection Test product (Liposomal amphotericin B for injection, Sichuan Huiyu Pharmaceutical Co., Ltd.), Reference product (AmBisome®, Astellas Pharma US Inc.) - Invasive Fungal Infections, Neutropenic Fever | Not applicable | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 58 | 2025-05-25 | 2026-05-27 |
| Human Bioequivalence Study of Amphotericin B Liposome for Injection Amphotericin B Liposome for Injection (strength: 50 mg, Sichuan Huiyu Pharmaceutical Co., Ltd.), Amphotericin B Liposome for Injection (trade name: Ambisome®, strength: 50 mg, MAH: Gilead Sciences) - Invasive Fungal Infections, Neutropenic Fever | Not applicable | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 42 | 2025-05-13 | 2026-05-22 |
| Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup Thermotherapy - Cutaneous Leishmaniasis | Not applicable | Recruiting | Armauer Hansen Research Institute, Ethiopia | 103 | 2025-04-24 | 2026-10-16 |
| Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases Peripheral venous blood sample - Leishmaniasis, Leptospirosis | Not applicable | Not yet recruiting | University Hospital, Montpellier | 183 | 2025-03-03 | 2025-03-05 |
| Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers In-house Western blot, specific for Leishmania - Leishmaniasis | Not applicable | Recruiting | IRCCS Sacro Cuore Don Calabria di Negrar | 170 | 2023-05-22 | 2024-03-12 |
| A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies biting by Phlebotomus duboscqi infected with Leishmania major - Leishmaniasis, Cutaneous Leishmaniases | Not applicable | Completed | University of York | 12 | 2021-10-16 | 2023-11-09 |
| Feasibility and Usability of Mobile Applications for Monitoring Cutaneous Leishmaniasis Treatment in Colombia Community based strategy to follow-up pactientes with Cutaneous Leishmaniasis - Cutaneous Leishmaniasis, American | Not applicable | Completed | Centro Internacional de Entrenamiento e Investigaciones Médicas | 105 | 2020-03-01 | 2022-09-09 |
| A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol Sand fly bite - Leishmaniasis, Cutaneous, Insect Bites | Not applicable | Completed | University of York | 12 | 2019-10-03 | 2022-10-31 |
| Defining Skin Immunity of a Bite of Key Insect Vectors in Humans One vector feeding, Four vector feeding - Zika, Dengue | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 95 | 2018-09-05 | 2021-12-08 |
| ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE - Blood sampling - Leishmaniasis, Cutaneous | Not applicable | Completed | Centre Hospitalier Universitaire de Nice | 30 | 2017-11-10 | 2022-03-18 |
| Improved Case Detection and Vector Control for Visceral Leishmaniasis Inesfly Paint, IDWL (1m), ITN (KO-Tab 123) - Visceral Leishmaniasis | Not applicable | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 202 | 2016-01-01 | 2020-01-14 |
| Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis. Local application pentostam, intra-lisional pentostam, fractional CO2 laser - Leishmaniasis | Not applicable | Unknown | Tel-Aviv Sourasky Medical Center | 20 | 2014-11-01 | 2017-01-04 |
| Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) rk28 ICT, IT LEISH (rK39), Immunochromatographic HAT test - Visceral Leishmaniasis, Human African Trypanosomiasis | Not applicable | Completed | University Hospital, Geneva | 1927 | 2013-01-01 | 2016-10-27 |
| Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis Herbal topical formulation - Leishmaniasis, Cutaneous | Not applicable | Completed | Jinnah Sindh Medical University | 78 | 2012-01-01 | 2021-04-12 |
| An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh Paromomycin sulfate - Visceral Leishmaniasis | Not applicable | Completed | PATH | 120 | 2011-01-01 | 2014-04-04 |
| Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine N-acetylcysteine, Pentavalent antimonial - Visceral Leishmaniasis, Immune Response | Not applicable | Unknown | Hospital Universitário Professor Edgard Santos | 40 | 2010-04-01 | 2010-06-08 |
| A Community Trial for Visceral Leishmaniasis (VL) Albendazole, Iron, Zinc and Vitamin A, Placebo - Visceral Leishmaniasis | Not applicable | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 200 | 2009-10-01 | 2012-11-14 |
| Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol meglumine antimoniate, allopurinol, meglumine antimoniate - Leishmaniasis, Cutaneous | Not applicable | Completed | Combined Military Hospital, Pakistan | 400 | 2008-01-01 | 2010-06-02 |
Showing 20 of 25. Sign in to see all of them.
Leishmaniasis, Cutaneous (10) · Leishmaniasis, Visceral (10) · Brucellosis (2) · Chikungunya Fever (2) · Febrile Neutropenia (2) · Insect Bites and Stings (2) · Invasive Fungal Infections (2) · Leptospirosis (2) · Malaria (2) · Rickettsia Infections (2) · Zika Virus Infection (2) · Anxiety Disorders (1) · Buruli Ulcer (1) · Cicatrix (1)
Euglenozoa Infections (25) · Infections (25) · Parasitic Diseases (25) · Protozoan Infections (25) · Vector Borne Diseases (25) · Skin Diseases (15) · Skin Diseases, Infectious (15) · Skin Diseases, Parasitic (15) · Skin and Connective Tissue Diseases (14) · Bacterial Infections and Mycoses (5) · Pathological Conditions, Signs and Symptoms (5) · Mosquito-Borne Diseases (4) · Bacterial Infections (3) · Chemically-Induced Disorders (3)
Injections (2) · Long-Term Synaptic Depression (2) · Acetylcysteine (1) · Albendazole (1) · Allopurinol (1) · Amphotericin B (1) · Blood Specimen Collection (1) · Hyperthermia, Induced (1) · Iron (1) · Meglumine Antimoniate (1) · Paromomycin (1) · Vitamin A (1) · Zinc (1) · liposomal amphotericin B (1)
International Centre for Diarrhoeal Disease Research, Bangladesh (3) · Hospital Universitário Professor Edgard Santos (2) · Sichuan Huiyu Pharmaceutical Co., Ltd (2) · University of York (2) · Armauer Hansen Research Institute, Ethiopia (1) · Banaras Hindu University (1) · Centre Hospitalier Universitaire de Nice (1) · Centro Internacional de Entrenamiento e Investigaciones Médicas (1) · Combined Military Hospital, Pakistan (1) · IRCCS Sacro Cuore Don Calabria di Negrar (1) · Jinnah Sindh Medical University (1) · Kenya Medical Research Institute (1) · London School of Hygiene and Tropical Medicine (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · PATH (1)
Bangladesh (4) · Brazil (2) · China (2) · Democratic Republic of the Congo (2) · Ethiopia (2) · France (2) · India (2) · Nepal (2) · Pakistan (2) · United Kingdom (2) · Cambodia (1) · Colombia (1) · Italy (1) · Kenya (1) · Nigeria (1)
Charles Lacey, BMBS, MD (2) · Qing Wen (2) · Beena Varghese, Dr (1) · Clive Davies, Dr. (1) · Dinesh Mondal, PhD (1) · Diwarkar Dinesh, Dr (1) · Edgar M Carvalho, MD (1) · Francois Chappuis, Dr. (1) · Gustavo H Penaloza, PhD (1) · Jean Claude Dujardin, Dr (1)
PMID 34053461, PMID 17682988, PMID 20126269, PMID 21460008, PMID 26496648, PMID 27812090, PMID 34693027, PMID 35491421, PMID 39095597